Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22104 |
ML-291
|
||
ML291 is a sufonamidebenzamide compound that induces the unfolded protein response (UPR) and overwhelms the adaptive capacity of UPR, resulting in apoptosis in various solid cancer models. It activates the PERK/eIF2a/CHOP apoptotic pathway of UPR and reduces leukemic cell burden [1]. |